Lantheus Holdings, Inc. (LNTH)
NASDAQ: LNTH · IEX Real-Time Price · USD
78.18
+10.79 (16.01%)
At close: May 2, 2024, 4:00 PM
77.70
-0.48 (-0.61%)
After-hours: May 2, 2024, 7:16 PM EDT
Lantheus Holdings Revenue
Lantheus Holdings had revenue of $1.37B in the twelve months ending March 31, 2024, with 32.98% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $369.98M with 23.00% year-over-year growth. In the year 2023, Lantheus Holdings had annual revenue of $1.30B with 38.65% growth.
Revenue (ttm)
$1.37B
Revenue Growth
+32.98%
P/S Ratio
4.13
Revenue / Employee
$1,554,471
Employees
834
Market Cap
5.36B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.30B | 361.37M | 38.65% |
Dec 31, 2022 | 935.06M | 509.85M | 119.91% |
Dec 31, 2021 | 425.21M | 85.80M | 25.28% |
Dec 31, 2020 | 339.41M | -7.93M | -2.28% |
Dec 31, 2019 | 347.34M | 3.96M | 1.15% |
Dec 31, 2018 | 343.37M | 12.00M | 3.62% |
Dec 31, 2017 | 331.38M | 29.53M | 9.78% |
Dec 31, 2016 | 301.85M | 8.39M | 2.86% |
Dec 31, 2015 | 293.46M | -8.14M | -2.70% |
Dec 31, 2014 | 301.60M | 17.93M | 6.32% |
Dec 31, 2013 | 283.67M | -4.43M | -1.54% |
Dec 31, 2012 | 288.11M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Organon & Co. | 6.26B |
Perrigo Company | 4.66B |
Bausch + Lomb | 4.31B |
Haemonetics | 1.27B |
Halozyme Therapeutics | 829.25M |
Doximity | 468.33M |
CRISPR Therapeutics AG | 371.21M |
Glaukos | 314.71M |
LNTH News
- 12 hours ago - Lantheus Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 14 days ago - Lantheus to Host First Quarter 2024 Earnings Conference Call and Webcast on May 2, 2024, at 8:00 a.m. Eastern Time - GlobeNewsWire
- 2 months ago - Lantheus to Present at the Leerink Partners Global Biopharma Conference 2024 - GlobeNewsWire
- 2 months ago - Lantheus Announces Promotion of Amanda Morgan to Chief Commercial Officer - GlobeNewsWire
- 2 months ago - Lantheus to Present at the TD Cowen 44th Annual Health Care Conference - GlobeNewsWire
- 2 months ago - Lantheus Reports Fourth Quarter and Full Year 2023 Financial Results - GlobeNewsWire
- 2 months ago - Lantheus Announces Collaboration to Provide Novel Tau Imaging Agent for Large Consortium Clinical Trial Sponsored by the National Institute on Aging - GlobeNewsWire
- 3 months ago - Lantheus to Host Fourth Quarter and Full Year 2023 Earnings Conference Call and Webcast on February 22, 2024, at 8:00 a.m. Eastern Time - GlobeNewsWire